2Sugarbaker Ph. Peritoneal carcinomatosisl natural history and rational therapelltic interyenticns using intraperitonedl chemnthcrapy. Cancer Treat Ras, 1996,81 (2) : 149-168.
4Tien Y W,Chang K J,Chiu Y F,et al.Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients[J].Ann Surg Oncol,2006,13(11):1357-1363.
5Dudek A Z,Mahaseth H.Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival[J].Cancer Invest,2005,23(3):193-200.
6Woo I S,Kim K A,Jeon H M,et al.Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma[J].Int J Cancer,2006,119(12):2901-2906.
7Koc M,Gocmen E,Kilic M,et al.Serum endostatin levels in gastric cancer patients:correlation with clinicopathological parameters[J J.Hepatogastroenterology,2006,53(70):616-618.
8Li V S, Wong C W, Chan T L, et al. Mutations of PIK3CA in gastric adenocarcinoma [J]. BMC Cancer, 2005,5 (29):1-6.
9Livark K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 [-DehaDehaC (T)]method [J]. Methods, 2001,25(4) :402-408.
10Hara A, Okayasu I. Cyelooxygenase-2 and inducible nitri oxide synthase expression in human astrocytic gliomas : correlation with angiogenesis and prognostic significance [J]. Acta Neuropathol, 2004, 108 ( 1 ) : 43-48.
